CAS: 72814-32-5 - 7-{(4S)-3-[(3R)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxoimidazolidin-4-yl}heptanoic acid
Fórmula:C19H32N2O5
InChI:InChI=1/C19H32N2O5/c22-16(14-8-4-3-5-9-14)12-13-21-15(18(25)20-19(21)26)10-6-1-2-7-11-17(23)24/h14-16,22H,1-13H2,(H,23,24)(H,20,25,26)/t15-,16+/s2
Clave InChI:InChIKey=ZIDQIOZJEJFMOH-REIYMHPCNA-N
SMILES:O=C(O)CCCCCCC1C(=O)NC(=O)N1CCC(O)C2CCCCC2
- Sinónimos:
- 4-Imidazolidineheptanoic acid, 3-(3-cyclohexyl-3-hydroxypropyl)-2,5-dioxo-, (R*,S*)-
- 4-Imidazolidineheptanoic acid, 3-[(3R)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo-, (4S)-rel-
- 4-Imidazolidineheptanoic acid, 3-[(3S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo-, (4R)-rel-
- 4-imidazolidineheptanoic acid, 3-[(3R)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo-, (4S)-
- Bw 245C
- rel-(4R)-3-[(3S)-3-Cyclohexyl-3-hydroxypropyl]-2,5-dioxo-4-imidazolidineheptanoic acid
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
BW 245C REF: 7W-GL8083CAS: 72814-32-5 | - - - | A consultar | Vie 13 Dic 24 | |
BW 245C REF: TR-B820013CAS: 72814-32-5 | - - - | 13.329,00 € | Mié 22 Ene 25 | |
BW 245C REF: 3D-XCA81432CAS: 72814-32-5 | Min. 95% | A consultar | Jue 23 Ene 25 | |
BW 245C REF: TM-T14842CAS: 72814-32-5 | ≥99% | 189,00 €~2.329,00 € | Jue 30 Ene 25 |
Ref: 7W-GL8083
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
BW 245C
CAS:72814-32-5
BW 245C is a synthetic, nonsteroidal compound that binds to the 2-adrenergic receptor, thereby inhibiting …
Fórmula:
C19H32N2O5
Pureza:
Min. 95%
Peso molecular:
368.47 g/mol
Ref: 3D-XCA81432
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 23 de Enero de 2025
BW 245C
CAS:72814-32-5
BW 245C is a DP1 agonist with an inhibitory effect on the aggregation response of …
Fórmula:
C19H32N2O5
Pureza:
≥99%
Forma y color:
Solid
Peso molecular:
368.47
Ref: TM-T14842
1mg | 189,00 € |
Entrega estimada en Estados Unidos, el Jueves 30 de Enero de 2025